Remove Engineering Remove Safety Remove Side effects
article thumbnail

Tackling immune-mediated disease with CAR Tregs

European Pharmaceutical Review

In this article, Sangamo Therapeutics’ Chief Scientific Officer, Jason Fortenot, explains why CAR Tregs may become transformational therapeutics for immune-mediated diseases, highlighting the challenges his company has overcome to get the first ever engineered Treg therapy into clinical trials. How do CAR Tregs differ from T cells?

article thumbnail

How to use Pay Per Click Advertising to Reach HCPs in Pharma

Pharma Marketing Network

Brand Authority: By appearing at the top of search engine results, pharmaceutical companies increase brand credibility among HCPs. This includes: Disclosing risks and side effects in ad copy when mentioning drug benefits. Avoiding misleading claims that exaggerate efficacy or safety.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Oncolytic viruses: past and present

European Pharmaceutical Review

the promise of leveraging oncolytic viruses stands out because of their excellent safety profile, minimal predicted side effects and potent ability to kill cancer cells while leaving healthy cells unscathed2. While oncolytic viruses do occur in nature, those used as therapies are typically engineered in a lab.

article thumbnail

ESMO: TIL therapy improves on Yervoy in melanoma trial

pharmaphorum

Health-related quality of life scores were also higher in patients treated with TIL than Yervoy, said Haanen, and no new safety issues were found with the cell therapy, which can be hard to tolerate with grade 3 or higher adverse events occurring in all patients treated.

article thumbnail

PPC Advertising Strategies for Pharma: Maximizing ROI

Pharma Marketing Network

The answer is simple search engines and social platforms are where patients and HCPs find information. A single misstepsuch as targeting the wrong audience or omitting safety disclaimers can lead to regulatory violations and ad disapprovals. With Google processing over 8.5 The challenge?

Pharma 52
article thumbnail

Developing novel therapies for NASH

European Pharmaceutical Review

It was engineered using a unique, proprietary glycoPEGylated technology to prolong the biological activity (half-life), while maintaining the efficacy of native FGF21, a metabolic hormone. Pegozafermin also has a favourable safety and tolerability profile, with few gastrointestinal (GI) side effects.

Medical 108
article thumbnail

Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry

Pharma Marketing Network

This blog post could provide information about the drug’s potential benefits, its side effects, and how it compares to other drugs on the market. For example, a pharmaceutical company could create a blog post about a new drug that it is developing.